Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
01/1999
01/21/1999WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators
01/21/1999WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
01/21/1999WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
01/21/1999WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES
01/21/1999WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
01/21/1999WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
01/21/1999WO1999002494A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
01/21/1999WO1999002252A1 Improvements in or relating to capsules
01/21/1999WO1999002156A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates
01/21/1999WO1999002144A1 Anion regulator for ruminants
01/21/1999CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives
01/21/1999CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
01/21/1999CA2294757A1 Anion regulator for ruminants
01/21/1999CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
01/20/1999EP0892063A2 Histidine kinase
01/20/1999EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC
01/20/1999EP0892057A2 Response regulator
01/20/1999EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor
01/20/1999EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives
01/20/1999EP0891776A1 Simethicone/anhydrous calcium phosphate compositions
01/20/1999EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
01/20/1999EP0891363A1 Heterocyclic compounds and their preparation and use
01/20/1999EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
01/20/1999EP0891355A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891353A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891335A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891332A1 6-phenylpyridyl-2-amine derivatives
01/20/1999EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity
01/20/1999EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity
01/20/1999EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
01/20/1999EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
01/20/1999EP0891186A1 Nasal administration of agents for treatment of delayed onset emesis
01/20/1999EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
01/20/1999EP0674624B1 Pyrazoles having crf antagonist activity
01/20/1999EP0630245B1 Protein kinase c inhibitor
01/20/1999CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives
01/20/1999CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
01/20/1999CN1205335A Tricyclic diazepine vasopression antagonists
01/19/1999US5861518 Phthalide compounds and their production process
01/19/1999US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases
01/19/1999US5861436 Inhibitors of the relese of tumor necrosis factor
01/19/1999US5861425 Indole-ethanamines
01/19/1999US5861418 Aminobenzoic acid derivatives
01/19/1999US5861412 Dihydro-isoquinoline compounds and their use as pharmaceuticals
01/19/1999US5861402 1,4-dihydropyridine compounds
01/19/1999US5861401 Treatment of congestive heart failure
01/19/1999US5861394 Use of N-substituted phenothiazines
01/19/1999US5861313 Method of isolating bile duct progenitor cells
01/19/1999US5861048 Dissolving aa alkaline earth metal or iron with a phosphorylated saccharide or one bound to a protein or peptide for use in feeds, fertilizers, foods beverages or tablets
01/19/1999CA2166902C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them
01/19/1999CA2108455C Pharmaceutical compositions against gastric disorders
01/19/1999CA2037663C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in the obtaining of anti-ulcer drugs, new complexes and chelates resp., of antibiotics with bivalent and/trivalent metals and processes for the obtaining thereof
01/18/1999CA2237050A1 Histidine kinase
01/18/1999CA2237043A1 Response regulator
01/14/1999WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family
01/14/1999WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them
01/14/1999WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life
01/14/1999WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
01/14/1999WO1999001452A1 Novel cycloalkyl substituted imidazoles
01/14/1999WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/14/1999WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine
01/14/1999WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
01/14/1999WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists
01/14/1999WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999WO1999001149A1 Health supplement
01/14/1999WO1999001136A1 Novel substituted imidazole compounds
01/14/1999WO1999001131A1 Novel substituted imidazole compounds
01/14/1999WO1999001130A1 Novel substituted imidazole compounds
01/14/1999WO1999001112A1 Multiple unit effervescent dosage form
01/14/1999WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses
01/14/1999WO1998040097A3 Bovine respiratory and enteric coronavirus as a vaccine
01/14/1999CA2297791A1 Health supplement
01/14/1999CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
01/14/1999CA2295762A1 Novel cycloalkyl substituted imidazoles
01/14/1999CA2295294A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999CA2295228A1 Novel substituted imidazole compounds
01/14/1999CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses
01/14/1999CA2294524A1 Novel substituted imidazole compounds
01/14/1999CA2294522A1 Novel substituted imidazole compounds
01/14/1999CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/14/1999CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
01/14/1999CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family
01/14/1999CA2236489A1 Novel compounds
01/13/1999EP0889961A2 Monocyte chemotactic protein-5 materials and methods
01/13/1999EP0889902A1 Antibiotic peptides from bovine milk
01/13/1999EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
01/13/1999EP0889888A1 Novel treatment for cns injuries
01/13/1999EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS
01/13/1999EP0889732A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders
01/13/1999EP0889729A1 Linseed drug
01/13/1999EP0889726A1 Novel cycloalkyl substituted imidazoles
01/13/1999EP0757670B1 Benzamide derivatives as vasopressin antagonists
01/13/1999CN1205010A Isoxazolidine derivatives
01/13/1999CN1205009A Pyrazolopyrimidines type compound
01/13/1999CN1205006A Substituted tetracyclic tetrahydrofuran derivatives
01/13/1999CN1204526A 'Huweiling' capsule- for protecting stomach
01/13/1999CN1204520A Medicine for treatment of lithiasis
01/13/1999CN1204515A Chinese medicinal preparation for treatment of toothache and method for preparation thereof
01/13/1999CN1204510A Stype using gossypol (and) its derivative as active component and use
01/13/1999CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor